Abstract
Most important quality attributes of any radiopharmaceutical (RPh) are its radiochemical purity (RCP) or content of radiochemical impurities (RCIs) that have to comply with respective norms and limits. However, at present, there is no unified approach to validation of analytical methods in the context of highly radioactive samples.The aim of the study was to develop an approach to validation of methods for determination of RCI content in RPhs.Materials and methods: the authors determined the content of RCIs in a radiopharmaceutical formulation containing a complex of technetium-99m and methylenediphosphonic acid by the radiometric method after isolation of impurities from the main compound by thin-layer chromatography using silica gel and methyl ethyl ketone (for sodium pertechnetate determination) and silica gel and 13.6% sodium acetate solution (for determination of hydrolysed reduced technetium-99m). The radioactivity was registered by a chromatogram scanner with a detector of gamma-rays with energies from 0.05 to 1.5 MeV.Results: the paper analyses existing official approaches to validation of analytical procedures and compares them with the results of experimental studies described in available publications. It assesses the validation parameters for compliance with the acceptance criteria set forth in the current regulations and substantiates selectivity of chromatographic determination of impurities under the selected test conditions. Coefficients of variation for repeatability, reproducibility, and accuracy did not exceed 4.5, 2.8, and 8.9%, respectively, given the relative error of not more than 10.5%. The study demonstrated signal linearity for the 10-fold dilution of the standardised sodium pertechnetate solution, it also demonstrated correspondence between the applied and detected radioactivity when performing the test in the impurity content range of 0.5–5%. The validation procedure was associated with significant radiation burden for the personnel of the quality control laboratory.Conclusions: the authors suggested a methodological approach to validation of methods for determination of RCI content in technetium-99m-based RPhs. This approach may be used in the development of a guideline on validation of analytical methods for RCP/RCI determination in RPhs, or for introduction of relevant sections into existing documents.
Highlights
Most important quality attributes of any radiopharmaceutical (RPh) are its radiochemical purity (RCP) or content of radiochemical impurities (RCIs) that have to comply with respective norms and limits
The study demonstrated signal linearity for the 10-fold dilution of the standardised sodium pertechnetate solution, it demonstrated correspondence between the applied and detected radioactivity when performing the test in the impurity content range of 0.5–5%
The validation procedure was associated with significant radiation burden for the personnel of the quality control laboratory
Summary
Радиофармацевтическую композицию (РК) готовили путем добавления 4 мл раствора Na99mТсО4 с необходимой объемной активностью (185– 1480 МБк/мл) во флакон, содержащий лиофилизированную смесь 10 мг метилендифосфоновой кислоты (МДФК) Полученную РК инкубировали при комнатной температуре в течение. 10 мин, после чего проводили определение содержания РХП (Na99mТсО4 и ГВТ). Раствор Na99mТсО получали путем элюирования генератора 99Мо/99mТс Россия) 0,9% раствором натрия хлорида, входящим в комплект поставки генератора, в соответствии с инструкцией по его эксплуатации. Активность полученного элюата измеряли на дозкалибраторе РИС А1 (ООО «НТЦ Амплитуда», Россия). 0,9% раствором натрия хлорида до требуемой объемной активности (185–1480 МБк/мл).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.